miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction]
Wang J, Wang G, Li B, Qiu C, He M. Onco Targets Ther. 2018;11:4461–4478. We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Since publication, concerns have been raised about the duplication of images in this article with those from other unrelat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-06-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/retraction-mir-141-3p-is-a-key-negative-regulator-of-the-egfr-pathway--peer-reviewed-fulltext-article-OTT |